A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
Author Correction
Please note number of errors appear in Table 1. The correct version is available here as a PDF (printer-friendly file). Please note, the changes are highlighted in yellow.
If you do not have Adobe Reader installed on your computer,
you can download this free-of-charge, please
Click here
Files in this Data Supplement:
- [View PDF] - Table 1 The frequency of BRCA1/2 Ashkenazi founder mutations among Israeli Ashkenazi men diagnosed with incident prostate cancer 1994-1995, and among men age 50 and over with no history of prostate cancer in the Washington Ashkenazi Study (WAS), and in the Molecular Epidemiology of Colorectal Cancer (MECC) study.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
